Abstract
In the chapter on the workup of the ovulatory factor, the difficulty in the diagnosis of the disturbed luteal phase was emphasized. Not only do multiple physiologic disorders probably cause the upset, but often the upset apparently comes and goes, occurring during one cycle but not another. These create difficulties in diagnosis, make rational therapy problematic, and, in particular, its evaluation almost impossible. Nevertheless, the luteal phase deficiency factor in infertility has been recognized for many years, and a number of treatment programs have been recommended.1,2
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rock J, Bartlett M: Biopsy studies of human endometrium criteria of dating and information about amenorrhea, menorrhea, and tissue of ovulation. JAMA 108:2022, 1937
Jones GES: Some newer aspects of management of infertility. JAMA 146:212, 1951
De Pozo E, Wyss H, Tolis G, Acaniz J, Campana A, Naftolin F: Prolactin and deficient luteal function. Obstet Gynecol 53:282, 1979
Ross GT, Cargille CM, Lipsett MB, et al: Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles. Rec Prog Horm Res 26:1, 1970
DiZerega GS, Hodgen GD: Luteal phase dysfunction infertility: A sequel to aberrant folliculogenesis. Fertil Steril 35:489, 1981
Jones GES: Luteal phase defects. In Behrman SJ, Kistner RW, (eds): Progress in Infertility, 2nd ed. Boston, Little Brown, 1975, p 299
Downs KA, Gibson M: Clomiphene citrate therapy for luteal phase defect. Fertil Steril 39:34, 1983
Quagllianello J, Weiss G: Clomiphene citrate in the management of infertility associated with shortened luteal phase. Fertil Steril 31:373, 1979
Huang K: The primary treatment of luteal phase inadequacy: Progesterone versus clomiphene citrate. Obstet Gynecol 155:824, 1986
Graff G: Suppression of cervical mucus during clomiphene therapy. Fertil Steril 22:209, 1971
Johansson EDB: Depression of progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol 68:779, 1971
Levy EP, Cohen A, Fraser FC: Hormone treatment during pregnancy and congenital heart defects. Lancet 1:611, 1973
Warnings on use of sex hormones in pregnancy. FDA Drug Bulletin 5:4, Jan–March, 1975
Check JH, Ranber A, Teichman M: The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil Steril 45:575, 1987
Katz Z, Lancet M, Skornik J, Chemke J, Magilner BM, Klinberg M: Teratogenecity of progestogens given during the first trimester of pregnancy. Obstet Gynecol 65:755, 1985
Jones GS: Luteal phase defects. In Gold JJ (ed): Gynecologic Endocrinology. Hagerstown, MD, Harper and Row, 1975, p 301
Garcia J, Jones GS, Wentz AC: The use of clomiphene citrate. Fertil Steril 28:707, 1977
Soules MR, Wiebe RH, Askel S, Hammond CB: The diagnosis and therapy of luteal phase deficiency. Fertil Steril 28:1033, 1977
Wentz AC, Herbert CM, Maxson WS, Garver CH: Outcome of progesterone treatment of luteal phase inadequacy. Fertil Steril 41:856, 1984
Rosenberg SM, Luciano AA, Riddick DH: The luteal phase defect: The relative frequency of, and encouraging response to treatment of vaginal progesterone. Fertil Steril 34:17, 1980
Huang KE, Muechler EK, Bonfiglio TA: Follicular phase treatment of luteal phase defect with follicle stimulating hormone in infertile women. Obstet Gynecol 64:32, 1984
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Publishing Corporation
About this chapter
Cite this chapter
Taymor, M.L. (1990). Treatment of Luteal Phase Defect. In: Infertility. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0627-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0627-6_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7899-3
Online ISBN: 978-1-4613-0627-6
eBook Packages: Springer Book Archive